“…They are also present in (natural, synthetic, and therapeutic) peptides, requiring their analytical determination as part of structure elucidation and/or quality control . A direct enantioresolution of underivatized and derivatized AAs using chiral stationary phases is nowadays the first choice. − Common examples for achiral precolumn derivatization supporting chiral separation comprise 6-aminoquinolyl- N -hydroxysuccinimidyl carbamate (AQC), , 1-fluoro-2,4-dinitrobenzene (DNB-F, Sanger’s reagent), 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD), dansyl chloride (Dns), , and 9-fluorenylmethyl-chloroformate (Fmoc-Cl). − These reagents commonly improve the retention and enantioselective behavior, , introduce chromophoric and fluorophoric detectability, can enhance detection sensitivity of AAs with poor electrospray ionization efficiency, and deliver signature ions (in MS/MS detection). , Chiral stationary phases, the workhorses for direct HPLC enantiomer separation, have often remarkable enantioselectivity, but suffer from limited chemoselectivity and lower efficiencies (compared to highly efficient RP congeners). , Hence, the combination of the two principles is quite obvious and should lead to an enhanced separation technology platform.…”